Interactions of angiotensin IV and oxytocin on behaviour in mice

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 8, Issue 3, 2007, Pages 133-138

  Gard, Paul R ^a   Daw, Pauline ^a   Mashhour, Zhila Sayyad ^a   Tran, Paula ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Angiotensin IV; Learned helplessness; Object recognition; Oxytocin; Oxytocinase

Indexed keywords

ANGIOTENSIN II [3-8]; ANTIDEPRESSANT AGENT; CYSTYL AMINOPEPTIDASE; OXYTOCIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; FORCED SWIMMING TEST; IN VITRO STUDY; IN VIVO STUDY; LEARNED HELPLESSNESS; LOCOMOTION; MALE; MEMORY; MOUSE; MYOMETRIUM; NONHUMAN; PREDICTION; RAT; RECOGNITION; UTERUS CONTRACTION; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; BEHAVIOR, ANIMAL; DRUG COMBINATIONS; DRUG INTERACTIONS; FEMALE; HELPLESSNESS, LEARNED; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OXYTOCICS; OXYTOCIN; PATTERN RECOGNITION, VISUAL; RATS; RATS, WISTAR; UTERUS;

EID: 36348953958     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2007.016     Document Type: Article

References (26)

1. Albiston AL, McDowall SG, Matsacos D et al. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase. J Biol Chem 2001;276:48623-6.
2. Lee RA, Mustafa T, Ye SY, McDowall SG, Chai SY, Albiston AL. Angiotensin AT(4) ligando are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). J Neurochem 2003;86:344-50.
3. Vauguelin G, Michotte Y, Smolders I et al. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. JRAAS 2002;3:195-204.
4. Zhang JH, Hanesworth JM, Sardinia MF, Jeremiah AA, Wright JW, Harding JW. Structural analysis of Ang IV receptor (AT4) from selected bovine tissues. J Pharm Exp Ther 1999;289:1075-83.
5. Lee J, Albiston A, Allen AM et al. Effect of ICV injection of AT(4) receptor ligand, Nle1-Ang IV and LVV-Hemorphin 7, on spatial learning in rats. Neuroscience 2004;124:341-9.
6. Pederson ES, Krishnan R, Harding JW, Wright JW. A role for the angiotensin AT(4) receptor subtype in overcoming scopolamine-induced spatial memory deficits. Regulatory Peptides 2001; 102:147-56.
7. Olson MI, Olson EA, Qualls JH, Stratton JJ, Harding JW, Wright JW. Norleucine (1)-angiotensin IV alleviates mecamylamine-induced spatial memory deficits. Peptides 2004;25:233-41.
8. Gard PR, Pavli A. Strain differences in the effects of angiotensin IV on object recognition in mice. Proceedings of the British Pharmacological Society December 2004, at http://www.pa2online.org/ Vol2Issue4abst074P.html
9. Lee J, Chai SY, Mendelsohn FAO, Morris MJ, Allen AM. Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. Neuropharmacology 2001;40:618-23.
10. Braszko JJ. Involvement of D-1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe (6) Angiotensin IV. Peptides 2004;25:1195-203.
11. Popik P, Vetulani J, Van Ree JM. Low-doses of oxytocin facilitate social recognition in rats. Psychopharmac 1992;106:71-4.
12. Popik P, Vetulani J, Van Ree JM. Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. Eur J Pharmacol 1996;308:113-16.
13. Arletti R, Benelli A, Poggioli R, Luppi P, Menozzi B, Bertolini A. Aged rats are still responsive to the antidepressant and memory-improving effects of oxytocin. Neuropeptides 1995;29:177-82.
14. Ferguson JN, Aldag JM, Insel TR, Young LJ. Oxytocin in the medial amygdale is essential for social recognition in the mouse. J Neurosci 2001;21:8278-85.
15. Popik P, Vetulani J. Opposite action of oxytocin and its peptide antagonists on social memory in rats. Neuropeptides 1991; 18:23-7.
16. Benelli A, Bertolini A, Poggioli R, Menozzi B, Basaglia R, Arletti. Polymodal dose-response curve for oxytocin in social recognition test. Neuropeptides 1995;28:251-5.
17. De Weid D, Gaffori O, Burbach JPH, Kovacs GL, Van Ree JM. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviour in rats. J Pharm Exp Ther 1987;241:268-74.
18. De Weid D, Elands J, Kovacs G. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behaviour: mediation by a cerebral neurohypophyseal hormone receptor. Proc Natl Acad Sci 1991;88:1494-8.
19. Wu W, Yu LC. Roles of oxytocin in spatial learning and memory in the nucleus basalis of Meynert in rats. Regulatory Peptides 2004; 120:119-25.
20. Nowabowska E, Kus K, Bobkiewicz-Koztowska T. Hertmanowska H. Role of neuropeptides in antidepressant and memory improving effects of venlafaxine. Pol J Pharmacol 2002;54:605-13.
21. Boccia MM, Kopf SR, Baretti CM. 1998. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice. Neurobiol Learning & Memory 1998;69:136-46.
22. Arletti R, Bertolini A. Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 1987; 41:1725-30.
23. Arletti R, Bertolini A. Influence of protease inhibitors on the antidepressant activity of oxytocin. Neuropeptides 1987; 10:241-8.
24. Burbach JPH, Bohus B, Kovacs GL, Nispen JW Van, Greven HM, De Wied D. Oxytocin is a precursor of potent behaviourally active neuropeptides. Eur J Pharmacol 1983; 94:125-31.
25. Braszko JJ, Kulakowska A, Winnicka MM, Karwowska Polecka W. Cgp 42112a abolishes facilitation of recognition caused by angiotensin II and angiotensin II (3-7) in rats. Acta Neurobiologiae Experimentalis 1997;57:227-34.
26. Porsolt RD. Animal model of depression. Biomedicine 1979; 30:139-40.